GAD1-mediated GABA elicits aggressive characteristics of human oral cancer cells
Zhichao Dou, Li Mao, Zeliang Shen, Hongjie Jiang, Xin Pang, Tianjiao Li, Xin‐hua Liang, Ya‐ling Tang
Abstract
Studies suggest that the expression of glutamate decarboxylase 1 (GAD1), γ-aminobutyric acid (GABA), and GABA receptors are involved in tumor progression. However, the underlying mechanisms of high expression and potential functions of GAD1 and GABA in oral squamous cell carcinoma (OSCC) are not known. In this study, we found that the expressions of GAD1 and GABA were considerably increased in OSCC samples, which were closely associated with clinical stage and lymph node metastasis . The knockdown of GAD1 expression significantly inhibited the proliferation, migration and invasion abilities of OSCC cells by reducing the expression of GABA-mediated GABA B receptors, which could be reversed by exogenous GABA, but did not cause excessive OSCC cell proliferation . And GABA secreted by OSCC cells promoted M2 macrophage polarization for inhibiting anti-tumor immunity by activating GABBR1/ERK/Ca 2+ . In addition, GABA/GABA B R promoted the proliferation and progression of OSCC xenograft tumor. Altogether, our results showed that GAD1 synthetized GABA to promote the malignant progression of OSCC and limits the anti-tumor immunity of macrophages, thereby targeting GABA can be a novel strategy for treating OSCC.